Page 54 - Eua News Today

AstraZeneca Plc is preparing to file for U.S. emergency use authorization (EUA) for its COVID-19 vaccine later this month or early April after accumulating enough data to judge the inoculation's efficacy, sources with knowledge of the ongoing clinical trial told Reuters on Friday. The number of COVID-19 cases among those who got the vaccine versus infections in participants who received a placebo will show how effective the AstraZeneca shot was at preventing illness in those age 18 and ove...

Interim data from a study showed 85% reduction in hospitalisation and deaths among patients, Vir and GSK said.

SunStar Dr. Joselito Retuya (Photo by City Information Office) + March 02, 2021 ALL Covid-19 vaccines that were given the emergency use authority (EUA) by the Food and Drug Administration (FDA) can almost 100 percent prevent severe cases or deaths from occurring, City Epidemiologist Dr. Joselito Retuya said. Retuya added that there are no Covid-19 vaccine that can block transmissions at present. "Matakdan gihapon ka pero instead nga mapadulong ka sa ngadto sa severe or kamatayon, p...

Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) has recommended the first single-shot COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, for individuals 18 years of age and older under the Emergency Use Authorization (EUA) issued by the U.S. Food and Drug Administration (FDA).

On Saturday, the FDA granted Emergency Use Authorization for the Johnson and Johnson coronavirus vaccine. A panel review concluded it is safe, more effective on serious cases of Covid-19 than on more

Johnson & Johnson’s COVID-19 vaccine is safe and effective, U.S. regulators said, a key...

As part of the review process, Dr Reddy’s will present the safety profile of the phase 2 study, and interim data of the phase 3 study, which is expected to complete by February 21, 2021. The vaccine is currently undergoing the phase 3 clinical trial in India

Dr.Reddys gets authorisation to start rolling out Sputnik V COVID-19 vaccine in India IANSFeb 19, 2021, 17:58 IST TOI Hyderabad, Feb Pharma major Dr. Reddys Laboratories Ltd on Friday announced that it has initiated the process with the Drugs Controller General of India ( DCGI) for Emergency Use Authorization ( EUA) of the well-studied human adenoviral vector-based platform vaccine candidate, Sputnik V. As part of the review process, Dr. Reddys will present the safety profile of the phase 2 s...

FDA grants EUA to BDs SARS-CoV-2/Flu assay FDA grants EUA to BDs SARS-CoV-2/Flu assay 15 February 2021 | News The BD® SARS-CoV-2/Flu assay is run on the BD MAX™ System and distinguishes between SARS-CoV-2 and Influenza A+B, providing a positive or negative result for each virus using a single specimen Source: PR Newswire BD (Becton, Dickinson and Company), a leading global medical technology company, has announced that the US Food and Drug Administration (FDA) has granted Emergency...

Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19PR NewswireSILVER SPRING, Md. 9, 2021 /PRNewswire/ -- Today, the U.